The global neurodegenerative diseases drugs market was valued at USD 44.69 Billion in 2024 and is projected to reach USD 88.74 Billion by 2034, growing at a CAGR of 7.10%. Growth is driven by the increasing prevalence of conditions like Alzheimer’s and Parkinson’s across key global markets. https://www.expertmarketresearch.com/reports/neurodegenerative-diseases-drugs-market